Study of Fasting Insulin and Insulin Resistance by Age, Sex, Race, BMI, and PCOS Status

What this Trial Is About

Researchers are investigating how fasting insulin and the Homeostatic Model Assessment of Insulin Resistance HOMA-IR vary by age, sex, raceethnicity, BMI, and polycystic ovary syndrome PCOS diagnosis. This study focuses on understanding metabolic health and insulin regulation across diverse groups to better identify risks for insulin-related conditions. It highlights the importance of measuring insulin and HOMA-IR alongside glucose levels to gain deeper insights into metabolic dysfunction. This observational study enrolls adults 18 years and older from varied backgrounds, including those with and without PCOS. Participants must have completed recent metabolic tests such as fasting insulin, hemoglobin A1c, lipid panels, and triglycerides after fasting at least eight hours. Data will be collected cross-sectionally, and analyses will explore how these factors influence insulin sensitivity and resistance. Participants will provide recent laboratory results performed by healthcare providers, labs, or using a specific insulin testing kit. Researchers will assess insulin and HOMA-IR levels, examining their relationship with demographic and clinical characteristics. The main outcome is measuring fasting insulin and HOMA-IR scores over a three-year period. The study aims to improve understanding of metabolic health markers to support better diagnosis and prevention strategies.

Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis